Cantargia to host R&D Day on new clinical results of nadunolimab in pancreatic cancer on April 24, 2023
LUND, Sweden, April 4, 2023 /PRNewswire/ -- Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today...
Source: europapress.es
Stay updated with breaking news from Phderic Van Cutsem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LUND, Sweden, April 4, 2023 /PRNewswire/ -- Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today...